作者
R Zini, Christophe Morin, A Bertelli, AA and Bertelli, JP Tillement
发表日期
1999/1/1
期刊
Drugs under experimental and clinical research
卷号
25
期号
2-3
页码范围
87-97
简介
The aim of this work was to investigate the possible effects of resveratrol on the mitochondrial respiratory chain in rat brains. Isolation of mitochondria was performed at 4 degrees C using differential centrifugation. Mitochondrial respiration rate (0.4 mg of protein/ml) was determined by measuring mitochondrial oxygen consumption with a Clark electrode at 37 degrees C. Respiratory control ratio (RCR) was evaluated as the state 3/state 4 ratio of oxidative phosphorylation with substrates adenosine 5'-diphosphate (ADP) and malate plus glutamate, respectively in the presence and in the absence of resveratrol. The rate of oxygen consumption by the different complexes was checked using rotenone (2 microM), malonate (10 mM), antimycin A (1 microM), potassium cyanide (KCN)(0.3 mM) and oligomycin (10 microM) to inhibit complexes II, III, IV, V and I, respectively. Moreover, enzyme activity determinations were checked as follows: the activities of complexes II-III were measured as the rate of cytochrome c reduction at 550 nm (37 degrees C) successively triggered either by succinate (complexes II and III) or by decylubiquinol (DUQH2)(complex III), in the presence and in the absence of resveratrol. Adenosine 5'-triphosphate (ATP) synthase activity was checked as ATP hydrolysis (ATPase) at 37 degrees C for 10 min from purified mitochondria on Percoll gradient. The inorganic phosphate (Pi) concentration was measured by the Fiske and Subbarow method. When complexes I to V were activated by glutamate plus malate, resveratrol (10 (-11)-10 (-4) M) significantly decreased RC (p< 0.001) following a biphasic curve with two EC50 values, 0.162+/-0 …
引用总数
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202428121377131213171216162730211420111119191054
学术搜索中的文章
R Zini, C Morin, A Bertelli, AA Bertelli, JP Tillement - Drugs under experimental and clinical research, 1999